Skip to main content
. 2018 Jul 2;10:1807–1816. doi: 10.2147/CMAR.S168515

Table S3.

Genotype frequencies of MYCN gene polymorphisms and neuroblastoma susceptibility (divided subjects)

Genotype Guangdong province Henan province Wenzhou subjects

Cases (N=275) Controls (N=531) AOR (95% CI)a P-valuea Cases (N=118) Controls (N=281) AOR (95% CI)a P-valuea Cases (N=36) Controls (N=72) AOR (95% CI)a P-valuea
rs57961569 G>A
 GG 124 (45.09) 230 (43.31) 1.00 64 (54.24) 113 (40.21) 1.00 14 (38.89) 29 (40.28) 1.00
 GA 114 (41.45) 243 (45.76) 0.87 (0.64–1.19) 0.371 42 (35.59) 135 (48.04) 0.54 (0.34–0.86) 0.009 15 (41.67) 34 (47.22) 0.93 (0.38–2.28) 0.877
 AA 37 (13.45) 58 (10.92) 1.19 (0.75–1.90) 0.459 12 (10.17) 33 (11.74) 0.64 (0.31–1.34) 0.237 7 (19.44) 9 (12.50) 1.61 (0.48–5.35) 0.439
 Additive 1.02 (0.82–1.26) 0.868 0.69 (0.49–0.97) 0.032 1.19 (0.66–2.14) 0.558
 Dominant 151 (54.91) 301 (56.69) 0.93 (0.69–1.25) 0.626 54 (45.76) 168 (59.79) 0.56 (0.36–0.86) 0.009 22 (61.11) 43 (59.72) 1.07 (0.46–2.47) 0.876
 Recessive 238 (86.55) 473 (89.06) 1.28 (0.82–1.99) 0.272 106 (89.83) 248 (88.26) 0.86 (0.43–1.74) 0.677 29 (80.56) 63 (87.50) 1.67 (0.56–5.01) 0.359
rs9653226 T>C
 TT 93 (33.82) 181 (34.09) 1.00 30 (25.42) 92 (32.74) 1.00 15 (41.67) 20 (27.78) 1.00
 TC 124 (45.09) 262 (49.34) 0.91 (0.66–1.27) 0.584 62 (52.54) 141 (50.18) 1.34 (0.81–2.23) 0.261 16 (44.44) 36 (50.00) 0.57 (0.23–1.41) 0.225
 CC 58 (21.09) 88 (16.57) 1.29 (0.85–1.96) 0.228 26 (22.03) 48 (17.08) 1.61 (0.86–3.04) 0.140 5 (13.89) 16 (22.22) 0.40 (0.12–1.36) 0.142
 Additive 1.10 (0.90–1.36) 0.354 1.28 (0.93–1.74) 0.129 0.62 (0.34–1.12) 0.115
 Dominant 182 (66.18) 350 (65.91) 1.01 (0.74–1.37) 0.964 88 (74.58) 189 (67.26) 1.41 (0.87–2.29) 0.166 21 (58.33) 52 (72.22) 0.52 (0.22–1.22) 0.132
 Recessive 217 (78.91) 443 (83.43) 1.36 (0.94–1.97) 0.101 92 (77.97) 233 (82.92) 1.34 (0.78–2.29) 0.293 31 (86.11) 56 (77.78) 0.56 (0.19–1.68) 0.299
rs13034994 A>G
 AA 166 (60.36) 300 (56.50) 1.00 77 (65.25) 176 (62.63) 1.00 22 (61.11) 50 (69.44) 1.00
 AG 90 (32.73) 202 (38.04) 0.80 (0.59–1.10) 0.171 32 (27.12) 89 (31.67) 0.84 (0.51–1.36) 0.472 12 (33.33) 20 (27.78) 1.41 (0.58–3.42) 0.444
 GG 19 (6.91) 29 (5.46) 1.18 (0.64–2.17) 0.602 9 (7.63) 16 (5.69) 1.37 (0.58–3.26) 0.476 2 (5.56) 2 (2.78) 2.39 (0.31–18.51) 0.404
 Additive 0.93 (0.73–1.19) 0.577 1.01 (0.70–1.44) 0.974 1.47 (0.72–3.00) 0.294
 Dominant 109 (39.64) 231 (43.50) 0.85 (0.63–1.14) 0.284 41 (34.75) 105 (37.37) 0.91 (0.58–1.44) 0.698 14 (38.89) 22 (30.56) 1.50 (0.64–3.50) 0.348
 Recessive 256 (93.09) 502 (94.54) 1.28 (0.70–2.33) 0.422 109 (92.37) 265 (94.31) 1.45 (0.6–3.41) 0.391 34 (94.44) 70 (97.22) 2.14 (0.28–16.16) 0.463
rs60226897 G>A
 GG 130 (47.27) 262 (49.34) 1.00 64 (54.24) 117 (41.64) 1.00 14 (38.89) 31 (43.06) 1.00
 GA 116 (42.18) 215 (40.49) 1.09 (0.80–1.48) 0.600 43 (36.44) 130 (46.26) 0.59 (0.37–0.94) 0.028 15 (41.67) 33 (45.83) 1.05 (0.43–2.57) 0.919
 AA 29 (10.55) 54 (10.17) 1.09 (0.66–1.80) 0.727 11 (9.32) 34 (12.10) 0.60 (0.28–1.26) 0.176 7 (19.44) 8 (11.11) 1.98 (0.59–6.63) 0.270
 Additive 1.06 (0.85–1.32) 0.604 0.70 (0.50–0.98) 0.037 1.32 (0.74–2.38) 0.350
 Dominant 145 (52.73) 269 (50.66) 1.09 (0.81–1.46) 0.574 54 (45.76) 164 (58.36) 0.60 (0.39–0.92) 0.019 22 (61.11) 41 (56.94) 1.23 (0.53–2.85) 0.624
 Recessive 246 (89.45) 477 (89.83) 1.05 (0.65–1.70) 0.835 107 (90.68) 247 (87.90) 0.76 (0.37–1.56) 0.453 29 (80.56) 64 (88.89) 1.93 (0.63–5.87) 0.248
Combined effect of risk genotypesb
 0 131 (47.64) 239 (45.01) 1.00 47 (39.83) 152 (54.09) 1.00 21 (58.33) 37 (51.39) 1.00
 1 24 (8.73) 78 (14.69) 0.56 (0.34–0.93) 0.025 12 (10.17) 22 (7.83) 1.83 (0.84–3.99) 0.130 1 (2.78) 7 (9.72) 0.23 (0.03–2.07) 0.191
 2 53 (19.27) 111 (20.90) 0.86 (0.58–1.28) 0.458 26 (22.03) 49 (17.44) 1.79 (1.00–3.21) 0.049 8 (22.22) 13 (18.06) 1.10 (0.39–3.15) 0.859
 3 67 (24.36) 103 (19.40) 1.20 (0.82–1.74) 0.349 33 (27.97) 58 (20.64) 1.84 (1.07–3.16) 0.027 6 (16.67) 15 (20.83) 0.66 (0.22–2.02) 0.469
Trend 1.04 (0.92–1.17) 0.520 1.24 (1.04–1.47) 0.014 0.92 (0.66–1.29) 0.629
 0–1 155 (56.36) 317 (59.70) 1.00 59 (50.00) 174 (61.92) 1.00 22 (61.11) 44 (61.11) 1.00
 2–3 120 (43.64) 214 (40.30) 1.15 (0.85–1.54) 0.362 59 (50.00) 107 (38.08) 1.65 (1.07–2.55) 0.024 14 (38.89) 28 (38.89) 1.00 (0.43–2.31) 0.999

Notes:

a

Adjusted for age and gender.

b

Risk genotypes were rs57961569 GG, rs9653226 CC, rs13034994 GG, and rs60226897 GG.

Abbreviations: AOR, adjusted odds ratio; CI, confidence interval.